Machine learning-driven drug repurposing for GPR17: activity prediction via graph neural networks and multistage computational validation
{{output}}
To identify novel GPR17-targeting ligands with potential relevance to multiple sclerosis (MS) therapy, we developed an integrated computational workflow combining graph neural network (GNN)-based prediction with multistage structure-based validation. GPR17 is ... ...
